Published in J Gen Virol on February 01, 1995
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol (2010) 1.94
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol (2000) 1.56
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol (2004) 1.50
Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol (2002) 1.45
Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol (2004) 1.34
Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. J Virol (2001) 1.33
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics. J Virol (2006) 1.12
Japanese encephalitis viruses from bats in Yunnan, China. Emerg Infect Dis (2009) 1.04
Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009. PLoS One (2011) 0.97
Induction of endoplasmic reticulum-derived replication-competent membrane structures by West Nile virus non-structural protein 4B. PLoS One (2014) 0.96
Mutational analysis of the West Nile virus NS4B protein. Virology (2012) 0.92
Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol (1998) 0.91
JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Virology (2007) 0.86
A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. PLoS Pathog (2014) 0.84
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother (2017) 0.82
Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol (2015) 0.79
Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. J Virol (2015) 0.77
Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain. Viruses (2017) 0.76
Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain. Vaccine (2013) 0.76
Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice. Am J Trop Med Hyg (2014) 0.76
Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus. PLoS One (2016) 0.75
Matrix and backstage: cellular substrates for viral vaccines. Viruses (2014) 0.75
Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol (1992) 17.82
Phylogeny of the genus Flavivirus. J Virol (1998) 8.87
Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol (1994) 4.47
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology (1986) 4.34
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol (1997) 3.30
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet (2001) 3.21
Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) (2008) 3.18
Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis (1993) 3.07
Flaviviridae. Intervirology (1985) 3.06
Tunable Fröhlich polarons in organic single-crystal transistors. Nat Mater (2006) 2.74
The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology (1989) 2.72
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol (2001) 2.59
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood (2001) 2.44
The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat Neurosci (1999) 2.32
Phylogeny of the Simbu serogroup of the genus Bunyavirus. J Gen Virol (2001) 2.30
Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome. Virology (1988) 2.22
Phylogenetic relationships of dengue-2 viruses. Virology (1993) 2.16
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
Interactions of Porphyromonas gingivalis with epithelial cells. Infect Immun (1993) 2.12
Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem (1993) 2.10
Phosphatidylinositol polyphosphate binding to the mammalian septin H5 is modulated by GTP. Curr Biol (2000) 2.09
Togaviridae. Intervirology (1985) 1.96
Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol (1986) 1.96
The 3'-non-coding regions of alphavirus RNAs contain repeating sequences. J Mol Biol (1982) 1.92
Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatr Serv (1999) 1.89
Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology (1986) 1.84
Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol (1986) 1.83
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry (1998) 1.78
Molecular and epidemiologic analysis of dengue virus isolates from Somalia. Emerg Infect Dis (1998) 1.77
Endoscopic optical coherence tomography based on a microelectromechanical mirror. Opt Lett (2001) 1.71
Genetic variation in the 3' non-coding region of dengue viruses. Virology (2001) 1.71
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1993) 1.67
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins. J Gen Virol (1987) 1.65
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Detecting bunyaviruses of the Bunyamwera and California serogroups by a PCR technique. J Clin Microbiol (1996) 1.62
A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J Virol Methods (2001) 1.55
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum (2013) 1.54
Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa. Virology (1996) 1.53
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A (1996) 1.51
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A (2000) 1.50
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol (1999) 1.50
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol (2008) 1.49
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull (2000) 1.47
Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol (2001) 1.47
3-D correlation-based speckle tracking. Ultrason Imaging (2005) 1.46
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J Gen Virol (1995) 1.44
Structural and nonstructural proteins of Saint Louis encephalitis virus. J Virol (1971) 1.43
Does competitive employment improve nonvocational outcomes for people with severe mental illness? J Consult Clin Psychol (2001) 1.42
Genetic evidence that epizootic Venezuelan equine encephalitis (VEE) viruses may have evolved from enzootic VEE subtype I-D virus. Virology (1992) 1.39
Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell (1996) 1.35
The actin-driven movement and formation of acetylcholine receptor clusters. J Cell Biol (2000) 1.34
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. Virology (1987) 1.34
The structural basis for the ligand specificity of family 2 carbohydrate-binding modules. J Biol Chem (2000) 1.33
Paths across generations: academic competence and aggressive behaviors in young mothers and their children. Dev Psychol (1998) 1.33
Evidence for synergy between family 2b carbohydrate binding modules in Cellulomonas fimi xylanase 11A. Biochemistry (2001) 1.31
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. Virology (1986) 1.31
An integrated target sequence and signal amplification assay, reverse transcriptase-PCR-enzyme-linked immunosorbent assay, to detect and characterize flaviviruses. J Clin Microbiol (1994) 1.30
Rapid identification of flaviviruses based on conserved NS5 gene sequences. J Virol Methods (1993) 1.30
Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology (1998) 1.30
Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.30
Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans. Surg Endosc (2003) 1.28
Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology (1998) 1.28
Structure of a family 15 carbohydrate-binding module in complex with xylopentaose. Evidence that xylan binds in an approximate 3-fold helical conformation. J Biol Chem (2001) 1.27
Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification. Ann N Y Acad Sci (1980) 1.27
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Togaviridae. Intervirology (1978) 1.24
Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus. J Gen Virol (1986) 1.23
Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study. Am J Clin Nutr (2001) 1.22
Job terminations among persons with severe mental illness participating in supported employment. Community Ment Health J (1998) 1.22
Genetic relatedness among structural protein genes of dengue 1 virus strains. J Gen Virol (1989) 1.21
Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing. J Virol (1977) 1.21
Improved sweat test method for the diagnosis of cystic fibrosis. Arch Dis Child (1984) 1.20
Direct sequencing of large flavivirus PCR products for analysis of genome variation and molecular epidemiological investigations. J Virol Methods (1992) 1.20
Imported yellow fever in a United States citizen. Clin Infect Dis (1997) 1.20
Amino-terminal amino acid sequences of structural proteins of three flaviviruses. Virology (1985) 1.20
Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Res (2001) 1.20